FDA moving to authorize Pfizer booster for 16-, 17-year-olds - report

The US Food and Drug Administration could authorize COVID-19 boosters from Pfizer Inc and BioNTech SE for use in 16- and 17-year olds as soon as next week, the Wall Street Journal reported late on Monday, citing a person familiar with the planning.